Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

American Heart Journal

Volumn 166, Issue 3, 2013, Pages 549-558

  Garcia, David A ^a   Wallentin, Lars ^b   Lopes, Renato D ^c   Thomas, Laine ^c   Alexander, John H ^c   Hylek, Elaine M ^d   Ansell, Jack ^e   Hanna, Michael ^f   Lanas, Fernando ^g   Flaker, Greg ^h   Commerford, Patrick ⁱ   Xavier, Denis ^j   Vinereanu, Dragos ^k   Yang, Hongqiu ^c   Granger, Christopher B ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^e LENOX HILL HOSPITAL   (United States)

^f BRISTOL MYERS SQUIBB   (United States)

^g UNIVERSIDAD DE LA FRONTERA   (Chile)

^h UNIVERSITY OF MISSOURI   (United States)

ⁱ UNIVERSITY OF CAPE TOWN   (South Africa)

^j ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^k CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; APIXABAN; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

AGE; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PYRAZOLES; PYRIDONES; STROKE; THROMBOEMBOLISM; TREATMENT OUTCOME; WARFARIN;

EID: 84883746925     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.05.016     Document Type: Article

References (11)

1. D.A. Garcia, R.D. Lopes, and E.M. Hylek New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs Thromb Haemost 104 2010 1099 1105
2. L.A. Linkins, P.T. Choi, and J.D. Douketis Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis Ann Intern Med 139 2003 893 900
3. S. Connolly, J. Pogue, and R. Hart Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
4. M.D. Ezekowitz, L. Wallentin, and S.J. Connolly Dabigatran and warfarin in vitamin K antagonist-naïve and -experienced cohorts with atrial fibrillation Circulation 122 2010 2246 2253
5. C.B. Granger, J.H. Alexander, and J.J. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
6. R.D. Lopes, J.H. Alexander, and S.M. Al-Khatib Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale Am Heart J 159 2010 331 339
7. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
8. F.R. Rosendaal, S.C. Cannegieter, and F.J. van der Meer A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 1993 236 239
9. E.M. Hylek, L. Frison, and L.E. Henault Disparate stroke rates on warfarin among contemporaneous cohorts with atrial fibrillation: potential insights into risk from a comparative analysis of SPORTIF III versus SPORTIF V Stroke 39 2008 3009 3014
10. E.M. Hylek, C. Evans-Molina, and C. Shea Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 2007 2689 2696
11. L. Wallentin, R.D. Lopes, and M. Hanna Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation Circulation 127 2013 2166 2176